发明名称 USE OF CROSSLINKED CRYSTALS AS A NOVEL FORM OF ENZYME IMMOBILIZATION
摘要 Disclosed are crosslinked protein crystals, characterised by the resistance against the exogenous proteolysis, so that the protein crystals keep at least 91 % of their original activity after the incubation during 3 hours under the presence of PronaseTM in concentration, initiating at the soluble protein the loss of at least 94 % of their original activity, or they have from 50 to 90 % of the catalytic activity of the soluble protein, or they have the half-time of the activity, which is more than 100 times than at the soluble protein, or they have a stability in the mixed, of 50 % volume aqueous-organic solvent, so that the crosslinked protein crystals keeps at least 40 % of their original activity after the incubation in the said solvent during at least one hour, or have improved profile of the activity pH in comparing with the soluble non-crosslinked protein form, or have better stability under the temperature from 55 to 65 C than soluble non-crosslinked protein form. Disclosed is also device containing them and their use.
申请公布号 SK5993(A3) 申请公布日期 1993.07.07
申请号 SK19930000059 申请日期 1991.07.30
申请人 VERTEX PHARMA 发明人 NAVIA MANUEL A;ST CLAIR NANCY L
分类号 G01N33/66;A61K38/43;A61K38/46;C07K5/072;C12M1/34;C12M1/40;C12N9/14;C12N9/20;C12N9/36;C12N9/54;C12N9/66;C12N9/80;C12N9/82;C12N11/00;C12P21/02;C12P21/06;C12Q1/00;C12Q1/37;G01N33/531;(IPC1-7):C12N9/00 主分类号 G01N33/66
代理机构 代理人
主权项
地址